Natriuretic Peptide Receptor 2 (NPR2)

AMDM; ANPRB; ANPb; NPRBi; NPR-B; GUCY2B; GUC2B; Guanylate Cyclase B; Atrial natriuretic peptide receptor type B

SPN	T739
HGNC	7944
MGI	97372
PubMed	24001744
RGD	620851
UniProt	P20594
Wiki	NPR2

NPRA and NPRB are linked to guanylyl cyclases, while NPRAC is G-protein linked and furthermore is a "clearance receptor" which acts to internalise and destroy the ligand. ANP activation of the ANP catalytic receptor will stimulate its intracellular guanylyl cyclase activity to convert GTP to cGMP. cGMP will then stimulate cGMP-dependent protein kinase (PKG) which will then induce smooth muscle relaxation. This is particularly important in the vasculature where vascular smooth muscle will bind ANP released as a result of increasing right atrial pressure and will cause them to relax. This relaxation will decrease total peripheral resistance which will in turn decrease venous return to the heart. The decrease in venous return to the heart will reduce the preload and will result in the heart having to do less work.

Reference

"Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases."
Nature 341:68-72(1989) [PubMed] [Europe PMC] [Abstract]

"Structure of the type B human natriuretic peptide receptor gene and association of a novel microsatellite polymorphism with essential hypertension."
Circ. Res. 84:605-610(1999) [PubMed] [Europe PMC] [Abstract]

"cGMP-dependent and -independent inhibition of a K+ conductance by natriuretic peptides: molecular and functional studies in human proximal tubule cells."
J. Am. Soc. Nephrol. 10:472-480(1999) [PubMed] [Europe PMC] [Abstract]

"DNA sequence and analysis of human chromosome 9."
Nature 429:369-374(2004) [PubMed] [Europe PMC] [Abstract]

"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]

"Extracellular domain-IgG fusion proteins for three human natriuretic peptide receptors. Hormone pharmacology and application to solid phase screening of synthetic peptide antisera."
J. Biol. Chem. 266:23060-23067(1991) [PubMed] [Europe PMC] [Abstract]

"Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP)."
Science 252:120-123(1991) [PubMed] [Europe PMC] [Abstract]

"An unappreciated role for RNA surveillance."
Genome Biol. 5:R8.1-R8.16(2004) [PubMed] [Europe PMC] [Abstract]

"Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux."
Am. J. Hum. Genet. 75:27-34(2004) [PubMed] [Europe PMC] [Abstract]

"Mass spectrometric identification of phosphorylation sites in guanylyl cyclase A and B."
Biochemistry 49:10137-10145(2010) [PubMed] [Europe PMC] [Abstract]

"Patterns of somatic mutation in human cancer genomes."
Nature 446:153-158(2007) [PubMed] [Europe PMC] [Abstract]

"An overgrowth disorder associated with excessive production of cGMP due to a gain-of-function mutation of the natriuretic peptide receptor 2 gene."
PLoS ONE 7:E42180-E42180(2012) [PubMed] [Europe PMC] [Abstract]

"A human skeletal overgrowth mutation increases maximal velocity and blocks desensitization of guanylyl cyclase-B."
Bone 56:375-382(2013) [PubMed] [Europe PMC] [Abstract]

"An activating mutation in the kinase homology domain of the natriuretic peptide receptor-2 causes extremely tall stature without skeletal deformities."
J. Clin. Endocrinol. Metab. 98:E1988-E1998(2013) [PubMed] [Europe PMC] [Abstract]

"Overgrowth syndrome associated with a gain-of-function mutation of the natriuretic peptide receptor 2 (NPR2) gene."
Am. J. Med. Genet. A 164A:156-163(2014) [PubMed] [Europe PMC] [Abstract]